Perseus Proteomics (TSE:4882) Total Assets : 円1,796.66 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Total Assets?

Perseus Proteomics's Total Assets for the quarter that ended in Dec. 2023 was 円1,796.66 Mil.

During the past 12 months, Perseus Proteomics's average Total Assets Growth Rate was -0.30% per year. During the past 3 years, the average Total Assets Growth Rate was 23.00% per year. During the past 5 years, the average Total Assets Growth Rate was -1.60% per year.

During the past 6 years, Perseus Proteomics's highest 3-Year average Total Assets Growth Rate was 23.00%. The lowest was -30.90%. And the median was -9.20%.

Total Assets is connected with ROA %. Perseus Proteomics's annualized ROA % for the quarter that ended in Dec. 2023 was -56.25%. Total Assets is also linked to Revenue through Asset Turnover. Perseus Proteomics's Asset Turnover for the quarter that ended in Dec. 2023 was 0.01.

Perseus Proteomics Total Assets Historical Data

The historical data trend for Perseus Proteomics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Total Assets Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

1,360.17

547.89

1,118.63

3,300.53

2,566.65

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial												2,745.16	2,566.65	2,152.55	1,989.79	1,796.66

Perseus Proteomics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Perseus Proteomics's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	2396.545	+	170.105
	=	2,566.65

Perseus Proteomics's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	1555.561	+	241.103
	=	1,796.66

Perseus Proteomics (TSE:4882) Total Assets Explanation

Total Assets is connected with ROA %.

Perseus Proteomics's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-1064.916	/	( (1989.786	+	1796.664)	/ 2 )
	=	-1064.916	/	1893.225
	=	-56.25 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Perseus Proteomics's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	20.748	/	( (1989.786	+	1796.664)	/ 2 )
=	20.748	/	1893.225
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Perseus Proteomics Total Assets Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines